Does neprilysin inhibition affect Alzheimer disease blood biomarkers in patients with heart disease?
This exploratory analysis of a randomized clinical trial evaluates the effect of neprilysin inhibition on Alzheimer disease blood biomarkers in patients with heart disease.
Brum et al. (Mon,) studied this question.